Livanova Plc Stock Price, News & Analysis

LivaNova PLC (NASDAQ:LIVN), a leader in medical technology, will participate in the American Epilepsy Society Annual Meeting from December 3-7 in Chicago. The company plans to present seven scientific posters highlighting its VNS Therapy System, which has been effective in treating drug-resistant epilepsy for over 25 years. Presentations will cover patient profiles, healthcare costs, and optimal treatment strategies. LivaNova demonstrates its dedication to neuromodulation research and collaboration with independent investigators to improve outcomes for epilepsy patients.

LivaNova PLC (LIVN) announced its participation in the 4th International Brain Stimulation Conference from December 6-9 in Charleston, S.C. The company will showcase its advancements in VNS Therapy^® for treatment-resistant depression. LivaNova is conducting the RECOVER study to evaluate VNS Therapy's effectiveness for difficult-to-treat depression.

LivaNova PLC (NASDAQ:LIVN) announced that CEO Damien McDonald will participate in the Piper Sandler 33rd Annual Virtual Healthcare Conference on December 1, 2021. This event showcases LivaNova's commitment to innovation in medical technology. The pre-recorded discussion will be available on LivaNova's website, remaining accessible for 90 days. With nearly 3,000 employees and a presence in over 100 countries, LivaNova aims to deliver life-changing medical technologies for patients worldwide. For more details, visit www.livanova.com.

LivaNova PLC (NASDAQ:LIVN) announced a ruling from the Court of Appeal of Milan, requiring the company to pay €453 million (around $519 million) for environmental liabilities linked to a former parent company, SNIA. LivaNova disputes the decision and plans to appeal to the Italian Supreme Court. This civil action may impact LivaNova's financial standing but the outcome of the appeal regarding joint liability is pending. The company maintains a strong global presence, operating in over 100 countries.

LivaNova PLC (NASDAQ:LIVN), a leading medical technology company, announces its CEO, Damien McDonald, will present at two significant healthcare conferences: the Stifel 2021 Virtual Healthcare Conference on November 17 at 10 a.m. Eastern and the Jefferies 2021 London Healthcare Conference on November 18 at 3 a.m. Eastern. Both presentations will be accessible via webcasts on LivaNova’s website, with replays available for 90 days. LivaNova, headquartered in London, employs around 3,000 people and operates in over 100 countries.

LivaNova PLC (NASDAQ:LIVN) announced a virtual Investor Day on December 7 from 8 a.m. to 12 p.m. CT. Executive leadership will present the long-range business plan aimed at maximizing growth and shareholder value. Additionally, the event will include overviews of the company’s franchises and strategic pipeline initiatives, with opportunities for Q&A sessions. Interested attendees can register via the LivaNova website. Following the event, a replay and presentation materials will be available online for one year.

LivaNova PLC (NASDAQ: LIVN) reported a 5.5% increase in third-quarter 2021 sales, reaching $253.2 million. Excluding the divested Heart Valves business, sales grew by 15.7%. Adjusted diluted EPS was $0.68, up from $0.38 in Q3 2020. The company raised 2021 guidance, projecting 8-11% net sales growth and adjusted EPS of $2.00 to $2.10. Operating income rose significantly to $17.9 million, with adjusted operating income at $47.9 million, a 49.1% increase. LivaNova also improved its cash flow and financial flexibility through an equity offering, retiring a $450 million term loan.

LivaNova PLC (NASDAQ:LIVN) will host a conference call on November 3, 2021 at 12 p.m. London time to discuss its Q3 2021 results. The results will be released prior to the call, which can be accessed via a live audiocast on the LivaNova website. Participants can also dial +1 844 200 6205 (U.S.) or +44 208 0682 558 (international) to join by phone using conference ID 386626. A replay will be available for 90 days after the call on their website.

LivaNova PLC (NASDAQ:LIVN) announced that CEO Damien McDonald will speak at the Baird 2021 Global Healthcare Conference on September 15, 2021, at 9:40 a.m. ET. The presentation will be available via live webcast on the LivaNova website. Participants are encouraged to log in 10 minutes early. A replay will be available for 30 days post-event. LivaNova, headquartered in London, is dedicated to improving patient outcomes with innovative medical technologies, employing around 3,000 staff globally.